Niagen Bioscience (NASDAQ:NAGE) Rating Increased to Strong-Buy at Wall Street Zen
Wall Street Zen upgraded shares of Niagen Bioscience (NASDAQ:NAGE – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Sunday morning. Other research analysts also recently issued reports about the company. Roth Capital reiterated a “buy” rating and issued a $23.00 target price (up from $10.00) […]
Wall Street Zen upgraded shares of Niagen Bioscience (NASDAQ:NAGE – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Sunday morning. Other research analysts also recently issued reports about the company. Roth Capital reiterated a “buy” rating and issued a $23.00 target price (up from $10.00) […]
